
Lung cancer is often found not when it is being looked for but by chance — on an image taken for another reason, or when a persistent cough, breathlessness or unexplained weakness appears. The first reaction is bewilderment: the illness sounds grave and there seems to be no time at all. German thoracic oncology answers that not with promises but with order: first establish precisely what kind of tumour it is and how far it has gone, and only then build a plan.
How people arrive
Usually with an X-ray or CT already done and a diagnosis that has been given at home. Sometimes the picture is clear, sometimes contradictory. Either way a German doctor begins by assembling the full picture afresh rather than acting on a single report: in lung cancer too much depends on the details.
First, an accurate diagnosis
The assessment uses CT of the chest and, to establish whether the tumour has gone beyond the lung, positron emission tomography (PET): it shows not the shape but the activity of the tissue and helps see where the disease is behaving aggressively. To obtain the tumour tissue itself, bronchoscopy or a targeted biopsy is done.
Then comes the most important part. Lung cancer is not one disease: small-cell cancer develops quickly, non-small-cell usually more slowly, and they are treated differently. And within non-small-cell cancer, tumours differ at the molecular level. Analysis of the tissue shows whether the tumour carries particular gene faults that targeted drugs act on, and features that indicate how useful immunotherapy would be. That is why in Germany treatment is not rushed before the molecular profile is ready: it often changes the whole approach.
Which approaches are used
The approach is decided by a tumour board — surgeon, oncologist, radiation oncologist and pathologist look at the case together. There is no single formula “against lung cancer”, and saying so is honest: the methods are combined for the particular case.
Where the tumour is operable it is removed — and increasingly gently, through small ports (thoracoscopically) rather than through a large incision, which makes recovery easier. Where an operation is impossible or unwise, modern radiotherapy helps: the stereotactic technique delivers the dose very precisely into the tumour while sparing the healthy tissue around it. Chemotherapy is used on indication, and targeted drugs and immunotherapy where the molecular analysis has shown that they suit this particular tumour. In advanced disease a distinct task is controlling the disease and quality of life: relieving symptoms, supporting breathing, giving the person their strength back.
A second opinion makes sense
Lung cancer is a situation where a second opinion is particularly justified, because the choice of treatment depends on correctly establishing the type and the molecular profile. A German specialist reviews your images and biopsy slides, orders any missing investigations and says whether they confirm the diagnosis and agree with the plan. This is not about frightening anyone but about restoring a sense of control: what is happening is clear, and so is what happens next.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.